IRAK3 and obesity due to melanocortin 4 receptor deficiency: These results implicate the importance of IRAKM kinase activity in IRAKM’s contribution to adipose tissue dysfunction and obesity, which can be further exploited to develop potential therapeutic strategy for treating obesity.